Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs.
about
Angiotensin II enhances adenylyl cyclase signaling via Ca2+/calmodulin. Gq-Gs cross-talk regulates collagen production in cardiac fibroblastsMotor dysfunction in type 5 adenylyl cyclase-null micePathophysiology of Heart Failure.Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stressesInhibition of Na+/H+-exchanger with sabiporide attenuates the downregulation and uncoupling of the myocardial beta-adrenoceptor system in failing rabbit hearts.Isoform-specific regulation of adenylyl cyclase: a potential target in future pharmacotherapy.Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytesDisruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload.Inhibition of cAMP-Dependent PKA Activates β2-Adrenergic Receptor Stimulation of Cytosolic Phospholipase A2 via Raf-1/MEK/ERK and IP3-Dependent Ca2+ Signaling in Atrial Myocytes.New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy.Neurohumoral activation in heart failure: the role of adrenergic receptors.Gene transfer for congestive heart failure: update 2013.Unanticipated signaling events associated with cardiac adenylyl cyclase gene transfer.Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure: A Randomized Clinical TrialNew and Emerging Therapies and Targets: Beta-3 Agonists.Ca2+ cycling and new therapeutic approaches for heart failure.G protein stoichiometry dictates biased agonism through distinct receptor-G protein partitioning.Adenylyl cyclase activity and function are decreased in rat cardiac fibroblasts after myocardial infarction.Effects of treatment with a 5-HT4 receptor antagonist in heart failure.Adenylyl cyclase regulation in heart failure due to myocardial infarction in rats.Type-specific regulation of adenylyl cyclase. Selective pharmacological stimulation and inhibition of adenylyl cyclase isoforms.Alterations of adenylyl cyclase and G proteins in aortocaval shunt-induced heart failure.Mechanism of cicaprost-induced desensitization in rat pulmonary artery smooth muscle cells involves a PKA-mediated inhibition of adenylyl cyclase.Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate.Laminin acts via focal adhesion kinase/phosphatidylinositol-3' kinase/protein kinase B to down-regulate beta1-adrenergic receptor signalling in cat atrial myocytes.Functional changes in adenylyl cyclases and associated decreases in relaxation responses in mesenteric arteries from diabetic rats.Identification of optimal reference genes for transcriptomic analyses in normal and diseased human heart.Study of adenylyl cyclase-GαS interactions and identification of novel AC ligands.
P2860
Q28569021-8896CAAD-CBDF-4A8E-8D5D-C07E139C3515Q28588207-41E30BD8-7F92-44F2-BCC2-02BB2A5E506EQ30315815-298C37A1-BDDB-4FD0-8641-6804E882D712Q33685872-E385FD5A-50B5-4693-AFF8-20E2A2E04912Q35100887-6407C930-4D95-43E4-919A-0698E3A37482Q35143923-CC4CC81D-953A-4422-B5EC-73591A80456FQ35785891-366BBBAE-FB12-4BBC-A5B1-D4316FB7C400Q35815013-59495506-FB76-47FE-B9F4-1ACDC789C76AQ36225196-C07F3D55-8B2E-435E-9F26-AD9B87F211E1Q36515530-52DFB198-E65B-422F-AD31-1D10B80A1BDEQ36579463-9070B2B2-04FE-4E25-8E0D-16E216309F02Q36698991-186BD07D-845B-45C9-90A8-820A5A6E8E1CQ37847462-5E34172B-9D2D-4326-9B84-28571E77B9E8Q38389875-7850824D-9AF1-4D68-967D-3C7CDB826C6CQ39062830-E7824326-375A-4D18-BB9D-47B1FD882BE2Q39493909-2C45C3F2-240D-48DE-B2A4-A155623CAC94Q41367745-8C62A238-AFEB-4CE5-9D3A-F50D760F85C4Q42518884-554E3C3A-FE7D-4F34-AEA2-EABE1B6FA3D2Q42625973-23E71A70-8F02-466B-8E01-D03B9ACB9B14Q43634603-E1BDB147-8CC4-49E5-96F3-5B5858E3DF49Q43767945-2785F966-6AD8-43E4-AB62-3FBC6C7D74C0Q44764142-D84013ED-5832-4D9A-832E-7808B89FF8ECQ44858976-D660A6A8-0F10-4C39-A73A-4C03E885D5C0Q45182671-0386802B-6C7F-4903-879E-139ACDC13338Q46209451-F9A48556-8095-482E-9711-3EFB45F59914Q46491173-79AA6238-B821-4AFB-BA96-A46ED2AF05B8Q47647169-C35440BB-7BCC-44A6-9473-3F4D6FA0222BQ47658620-E3DD9963-FF9A-4D2C-9F9E-C214B9277383
P2860
Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Downregulation of adenylylcycl ...... induced heart failure in dogs.
@ast
Downregulation of adenylylcycl ...... induced heart failure in dogs.
@en
Downregulation of adenylylcycl ...... induced heart failure in dogs.
@nl
type
label
Downregulation of adenylylcycl ...... induced heart failure in dogs.
@ast
Downregulation of adenylylcycl ...... induced heart failure in dogs.
@en
Downregulation of adenylylcycl ...... induced heart failure in dogs.
@nl
prefLabel
Downregulation of adenylylcycl ...... induced heart failure in dogs.
@ast
Downregulation of adenylylcycl ...... induced heart failure in dogs.
@en
Downregulation of adenylylcycl ...... induced heart failure in dogs.
@nl
P2093
P2860
P356
P1476
Downregulation of adenylylcycl ...... induced heart failure in dogs.
@en
P2093
D E Vatner
K Komamura
R P Shannon
S F Vatner
S Katsushika
Y Ishikawa
P2860
P304
P356
10.1172/JCI117219
P407
P577
1994-05-01T00:00:00Z